Case File №
#VI-2026-0370
Hunan GoodPeptides Biotech Co
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
33 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | A Great | 2 | 9.0 | 8.0 | 10.0 | 25 Jul 2025 |
| AA Water | X N/A | 1 | 8.0 | 8.0 | 8.0 | 11 Jun 2025 |
| Adipotide | X N/A | 1 | 9.6 | 9.6 | 9.6 | 13 Jun 2025 |
| AHK-CU | X N/A | 1 | 9.2 | 9.2 | 9.2 | 20 Jun 2025 |
| Anadrol (Oxymetholone) | X N/A | 1 | 9.6 | 9.6 | 9.6 | 11 Jun 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 8.0 | 8.0 | 8.0 | 11 Jun 2025 |
| Cardiogen | X N/A | 1 | 5.3 | 5.3 | 5.3 | 28 Mar 2025 |
| Cerebrolysin | X N/A | 1 | 6.6 | 6.6 | 6.6 | 7 May 2025 |
| CJC-1295 With DAC | X N/A | 1 | 7.3 | 7.3 | 7.3 | 21 May 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 8.6 | 8.6 | 8.6 | 17 Dec 2024 |
| Dianabol | X N/A | 1 | 10.0 | 10.0 | 10.0 | 6 May 2025 |
| Dihexa | X N/A | 1 | 6.5 | 6.5 | 6.5 | 17 Dec 2024 |
| EPO | X N/A | 1 | 6.4 | 6.4 | 6.4 | 27 Feb 2025 |
| GHRP-2 Acetate | X N/A | 1 | 10.0 | 10.0 | 10.0 | 13 Jun 2025 |
| GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | X N/A | 1 | 9.1 | 9.1 | 9.1 | 17 Dec 2024 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 10.0 | 10.0 | 10.0 | 17 Dec 2024 |
| GW-501516 (Cardarine) | X N/A | 1 | 9.6 | 9.6 | 9.6 | 2 Apr 2025 |
| Halotestin (Fluoxymesterone) | X N/A | 1 | 7.6 | 7.6 | 7.6 | 27 Feb 2025 |
| Norfentanyl CAS 1609-66-1 | X N/A | 1 | 8.8 | 8.8 | 8.8 | 6 May 2025 |
| PE 22-28 | X N/A | 1 | 9.6 | 9.6 | 9.6 | 9 Jun 2025 |
| Prostamax | X N/A | 1 | 9.3 | 9.3 | 9.3 | 11 Jun 2025 |
| Proviron (Mesterolone) | X N/A | 1 | 7.5 | 7.5 | 7.5 | 16 Mar 2025 |
| PTD-DBM | X N/A | 1 | 10.0 | 10.0 | 10.0 | 3 Jun 2025 |
| RAD140 | X N/A | 1 | 10.0 | 10.0 | 10.0 | 9 Jun 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 9.1 | 9.1 | 9.1 | 7 May 2025 |
| Selank | X N/A | 1 | 9.9 | 9.9 | 9.9 | 13 Feb 2025 |
| Sildenafil Raw | X N/A | 1 | 7.9 | 7.9 | 7.9 | 21 May 2025 |
| SR9009 | X N/A | 1 | 7.3 | 7.3 | 7.3 | 3 Jul 2025 |
| Super Shred | X N/A | 1 | 9.3 | 9.3 | 9.3 | 13 Feb 2025 |
| Test Cypionate | X N/A | 1 | 9.6 | 9.6 | 9.6 | 13 Feb 2025 |
| Tren Hex | X N/A | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 |
| Turinabol | X N/A | 1 | 8.6 | 8.6 | 8.6 | 8 Jul 2025 |
| Vilon | X N/A | 1 | 8.6 | 8.6 | 8.6 | 21 May 2025 |
Exhibit II
Evidence Log
34 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | Dihexa | 6.8 A | 50mg | 49.5mg | -0.9% | 99.29% | aushqe | Lab B | Community |
| 24 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 10.0 A | 2mg | 1.9mg | -2.8% | 99.57% | 7va83b | Lab F | Community |
| 24 May 2026 | Sildenafil Raw | 8.6 A | 10g | 9.2g | -7.6% | 96.10% | qb04k5 | Lab C | Public |
| 24 May 2026 | Turinabol | 8.6 A | 20mg | 17.2mg | -13.9% | 96.89% | g7vm72 | Lab D | Public |
| 24 May 2026 | AHK-CU | 9.9 A | 2mg | 1.9mg | -3.4% | 99.08% | qelbjg | Lab E | Community |
| 24 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 9.0 A | 20mg | 24.0mg | +19.9% | 98.62% | tcplgc | Lab A | Public |
| 24 May 2026 | CJC-1295 With DAC | 5.7 B | 10mg | 9.4mg | -5.9% | 97.36% | 1l7ebq | Lab G | Public |
| 24 May 2026 | AA Water | 6.9 A | 10mg | 8.6mg | -14.0% | 96.53% | 8upk3k | Lab A | Public |
| 23 May 2026 | PTD-DBM | 10.0 A | 50mg | 55.9mg | +11.9% | 97.69% | u17dzn | Lab E | Public |
| 21 May 2026 | Proviron (Mesterolone) | 9.9 A | 50mg | 43.4mg | -13.2% | 95.66% | 7ahy4u | Lab A | Public |
| 20 May 2026 | BPC157 10mg + TB500 10mg Blend | 8.3 A | 5mg | 4.9mg | -1.7% | 99.46% | lze5ld | Lab G | Public |
| 20 May 2026 | GHRP-2 Acetate | 10.0 A | 5mg | 5.0mg | -0.4% | 97.26% | kliu69 | Lab A | Public |
| 20 May 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 10.0 A | 10mg | 11.1mg | +11.0% | 95.33% | 95bsvd | Lab C | Public |
| 20 May 2026 | GW-501516 (Cardarine) | 9.3 A | 50mg | 51.7mg | +3.4% | 96.43% | e39lm4 | Lab F | Community |
| 19 May 2026 | SR9009 | 9.0 A | 25mg | 27.7mg | +10.9% | 95.01% | 2atfke | Lab D | Community |
| 19 May 2026 | Super Shred | 8.6 A | 300mg/ml | 305.9mg/ml | +2.0% | 96.23% | bvqy4o | Lab F | Public |
| 17 May 2026 | Cerebrolysin | 4.7 C | 15mg | 13.1mg | -12.6% | 96.49% | lk2xow | Lab F | Public |
| 29 Jan 2026 | Dianabol | 10.0 A | 50mg | 55.6mg | +11.3% | 98.88% | fh0udu | Lab A | Public |
| 29 Jan 2026 | RAD140 | 8.4 A | 100mg | 110.1mg | +10.1% | 95.26% | ztng69 | Lab G | Community |
| 7 Jan 2026 | Selank | 10.0 A | 20mg | 22.3mg | +11.4% | 98.24% | p1owhm | Lab E | Community |
| 6 Jan 2026 | Adipotide | 9.0 A | 10mg | 10.9mg | +9.4% | 97.40% | 2icntc | Lab G | Community |
| 6 Jan 2026 | Cardiogen | 5.3 B | 50mg | 56.5mg | +13.1% | 99.64% | i7b8w9 | Lab D | Community |
| 6 Jan 2026 | Selank 10mg + Semax 10mg Blend | 7.7 A | 20mg | 20.4mg | +2.1% | 97.01% | gtq46n | Lab E | Public |
| 12 Dec 2025 | Anadrol (Oxymetholone) | 9.5 A | 10mg | 10.5mg | +5.5% | 95.98% | xpdiuq | Lab A | Community |
| 5 Dec 2025 | Prostamax | 9.0 A | 50mg | 44.2mg | -11.6% | 95.76% | z6y0gc | Lab E | Public |
| 14 Nov 2025 | EPO | 7.6 A | 20mg | 22.2mg | +11.0% | 96.63% | f1wo08 | Lab B | Community |
| 14 Nov 2025 | Halotestin (Fluoxymesterone) | 9.7 A | 25mg | 26.9mg | +7.6% | 97.50% | 4xiywz | Lab G | Public |
| 4 Nov 2025 | PE 22-28 | 9.4 A | 20mg | 19.9mg | -0.7% | 96.09% | k1ya1k | Lab F | Public |
| 17 Oct 2025 | Norfentanyl CAS 1609-66-1 | 8.1 A | 1g | 1.1g | +6.3% | 95.45% | 0ohxzj | Lab G | Public |
| 17 Oct 2025 | Tren Hex | 10.0 A | 100mg/ml | 92.7mg/ml | -7.3% | 97.17% | xg0is0 | Lab B | Public |
| 9 Oct 2025 | Test Cypionate | 9.7 A | 250mg/ml | 270.8mg/ml | +8.3% | 98.94% | xmwhj6 | Lab D | Public |
| 3 Oct 2025 | Vilon | 6.7 A | 5mg | 4.8mg | -4.5% | 95.59% | s92ajw | Lab G | Public |
| 25 Jul 2025 | Tirzepatide | 8.0 A | 5mg | 4.8mg | -4.0% | 99.91% | (no batch ID) | Lab E | Public |
| 25 Jul 2025 | Tirzepatide | 10.0 A | 10mg | 9.57mg | -4.3% | 99.92% | 20250220-L007 | Lab E | Public |
— END OF EVIDENCE LOG —